Management of Acute Alcohol Withdrawal
Benzodiazepines are the first-line pharmacological treatment for acute alcohol withdrawal syndrome, with symptom-triggered dosing guided by validated assessment scales being the preferred approach. 1, 2, 3
Initial Assessment and Risk Stratification
Use the Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar) to assess withdrawal severity and guide treatment intensity 3, 4. Screen all patients for:
- Electrolytes, hepatic function, and substance use panels 5
- Risk factors for severe withdrawal: history of seizures, delirium tremens, severe dependence, concurrent medical/psychiatric illness, inadequate social support 1
- Thiamine deficiency indicators: malnutrition, suspected Wernicke's encephalopathy 1
Setting Determination
Outpatient management is appropriate for mild to moderate withdrawal without risk factors for severe complications 3, 6. Inpatient admission is required for:
- Risk of severe withdrawal or delirium tremens
- History of withdrawal seizures
- Concurrent serious medical or psychiatric disorders
- Lack of adequate social support 1
Pharmacological Management
Benzodiazepines (First-Line)
Diazepam tapering regimens are recommended with daily staged supply from pharmacy or clinic 6. Symptom-triggered dosing using CIWA-Ar scores is more effective than fixed-schedule dosing 4.
- Moderate to severe withdrawal: Benzodiazepines are essential for alleviating withdrawal discomfort, preventing seizures, and preventing delirium 1, 2
- Mild symptoms: Consider carbamazepine or gabapentin as alternatives 3
Phenobarbital as Adjunct
For moderate to severe AWS requiring hospital admission, add phenobarbital to benzodiazepines rather than using benzodiazepines alone 7. This combination reduces benzodiazepine requirements and may prevent respiratory depression 8.
Thiamine Supplementation (Essential)
All patients must receive thiamine to prevent Wernicke-Korsakoff encephalopathy 1, 2:
- Oral thiamine for standard cases
- Parenteral thiamine for high-risk patients (malnourished, severe withdrawal) or suspected Wernicke's encephalopathy 1
Adjunctive Medications
Antipsychotics should NOT be used as stand-alone treatment 1. Use only as adjunct to benzodiazepines for:
- Severe withdrawal delirium unresponsive to adequate benzodiazepine doses 1
- Persistent agitation/delusions 8
- Haloperidol or droperidol are options 7
Alpha-2 agonists (clonidine) and beta-blockers may be added to reduce autonomic symptoms and benzodiazepine requirements 8.
Anticonvulsants should NOT be used for prevention of alcohol withdrawal seizures 1. Phenytoin is not superior to placebo for uncomplicated withdrawal seizures 4.
Critical Pitfalls to Avoid
- Do not use antipsychotics alone for withdrawal management—they do not prevent seizures or delirium and may lower seizure threshold 1
- Do not prescribe large quantities of psychoactive medications—dispense small amounts or supervise each dose to reduce misuse risk 1
- Do not forget thiamine—administer before or concurrent with glucose to prevent precipitating Wernicke's encephalopathy 1
- Monitor outpatients daily for up to 5 days after last drink to verify symptom improvement 3
Post-Withdrawal Management
Initiate long-term treatment for alcohol use disorder immediately, including:
- Pharmacotherapy: Naltrexone (prevents return to heavy drinking), acamprosate (maintains abstinence), or disulfiram (supervised settings only) 1, 6
- Psychosocial support: Cognitive behavioral therapy, motivational interviewing 1, 6
- Peer support programs: Alcoholics Anonymous or SMART Recovery 6
The evidence strongly supports that withdrawal management alone has high relapse rates; longer-term maintenance treatment is essential for sustained recovery 9, 3.